Spruce Biosciences, Inc. Public Float
Spruce Biosciences, Inc. (SPRB) had Public Float of $2.80 million as of 2025-06-30, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-09
- 2025-06-30: Entity Public Float $2.80M.
- 2024-06-28: Entity Public Float $18.80M.
- 2023-06-30: Entity Public Float $75.00M.
- 2022-06-30: Entity Public Float $22.50M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $2.80M 10-K · filed 2026-03-09 |
| 2024-06-28 | $18.80M 10-K · filed 2025-04-15 |
| 2023-06-30 | $75.00M 10-K · filed 2024-03-18 |
| 2022-06-30 | $22.50M 10-K · filed 2023-03-16 |
| 2021-06-30 | $142.93M 10-K · filed 2022-03-14 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |